Cybersecurity in Medical Devices: Refuse to Accept Policy for Cyber Devices and Related Systems Under Section 524B of the FD&C Act
This guidance describes FDA's RTA policy for premarket submissions submitted for cyber devices before October 1, 2023.
Stay updated with breaking news from Docket Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This guidance describes FDA's RTA policy for premarket submissions submitted for cyber devices before October 1, 2023.
The U.S. Food and Drug Administration (FDA) has published updated draft guidance for industry, Electronic Systems, Electronic Records, and Electronic Signatures in Clinical...
Final guidance provides performance criteria for soft daily wear contact lenses (21 CFR 886.5925, LPL) in support of the Safety and Performance Based Pathway.
FDA developed this guidance document to outline general considerations for certain animal studies used to support device premarket submissions.
Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics